Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 268,000 | 255,000 | 265,000 | 275,000 | 288,000 |
| Cost of Goods | 35,000 | 24,000 | 33,000 | 27,000 | 25,000 |
| Gross Profit | 233,000 | 231,000 | 232,000 | 248,000 | 263,000 |
| Operating Expenses | 149,000 | 115,000 | 347,000 | 185,000 | 146,000 |
| Operating Income | 84,000 | 116,000 | -115,000 | 63,000 | 117,000 |
| Interest Expense | 10,000 | 7,000 | 24,000 | 11,000 | 16,000 |
| Other Income | 4,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Pre-tax Income | 78,000 | 111,000 | -137,000 | 54,000 | 103,000 |
| Income Tax | 8,000 | 18,000 | 8,000 | 4,000 | 30,000 |
| Net Income Continuous | 70,000 | 93,000 | -145,000 | 50,000 | 73,000 |
| Net Income | $70,000 | $93,000 | $-145,000 | $50,000 | $73,000 |
| EPS Basic Total Ops | 0.50 | 0.65 | -1.00 | 0.35 | 0.50 |
| EPS Basic Continuous Ops | 0.48 | 0.64 | -1.01 | 0.35 | 0.51 |
| EPS Diluted Total Ops | 0.45 | 0.60 | -1.00 | 0.35 | 0.50 |
| EPS Diluted Continuous Ops | 0.47 | 0.62 | -0.95 | 0.33 | 0.49 |
| EBITDA(a) | $88,000 | $119,000 | $-111,000 | $68,000 | $119,000 |